Center For Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,596
Closed -$510K 115
2022
Q4
$510K Sell
4,596
-2,634
-36% -$269K 0.48% 55
2022
Q3
$623K Sell
7,230
-1,173
-14% -$105K 0.62% 38
2022
Q2
$766K Buy
8,403
+5,063
+152% +$449K 0.71% 29
2022
Q1
$274K Buy
3,340
+398
+14% +$31.4K 0.21% 95
2021
Q4
$225K Sell
2,942
-1,134
-28% -$90.3K 0.17% 106
2021
Q3
$306K Buy
4,076
+145
+4% +$11K 0.26% 68
2021
Q2
$306K Buy
3,931
+589
+18% +$43.8K 0.26% 69
2021
Q1
$246K Sell
3,342
-1,068
-24% -$78.8K 0.24% 74
2020
Q4
$344K Buy
+4,410
New +$337K 0.34% 50

Other funds holding MRK

Center For Asset Management's MRK Position: Q1 2023 in Review

Center For Asset Management sold out of Merck (MRK) in Q1 2023, closing a stake of 4,596 shares — an estimated $510K sold.

Center For Asset Management first reported a position in MRK in Q4 2020 and held it in 9 quarters. The position peaked at $766K in Q2 2022. 3,179 funds tracked by Wall St. Rank hold MRK as of Q1 2023.

  • Center For Asset Management reported no remaining Merck position as of Q1 2023 after selling out during the quarter.
  • Center For Asset Management sold 4,596 Merck shares in Q1 2023, an estimated $510K.
  • Center For Asset Management first reported a position in Merck in Q4 2020 and held it in 9 quarters.
  • Center For Asset Management's Merck position peaked at $766K in Q2 2022.
  • 3,179 funds tracked by Wall St. Rank held Merck as of Q1 2023.

Based on Center For Asset Management's 13F filing for Q1 2023, filed 24 Apr 2023.